<DOC>
	<DOC>NCT02862613</DOC>
	<brief_summary>Objectives: To evaluate the safety and effectiveness of cell therapy using Precision Cells Combined With TACE in Advanced Liver Cancer. Eligibility: Individuals greater than or equal to 18 years of age and less than or equal to 65 years of age who have been diagnosed with Advanced Liver Cancer.</brief_summary>
	<brief_title>Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer</brief_title>
	<detailed_description>A total of 40 patients may be enrolled over a period of 1-2 years.</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Age 18~65 years old, male or female; Life expectancy≥6 months; ECOG score: 03; Advanced Malignancies (lung cancer, gastric cancer) were diagnosed by pathological or clinical physicians,and Diagnosis of hepatocellular carcinoma (HCC), surgery can not be performed but TACE treatment can be carried out; Enough venous channel, no other contraindications to the separation and collection of white blood cells; Laboratory examination: white blood cell≥3 x 10*9/L, blood platelet count≥60 x 10*/L, hemoglobin≥85g/L; lymphocyte count≥15%, total bilirubin≤100 mol/L; ALT and AST less than five times of the normal level; serum creatinine less than 1.5 times of the normal level; Signed informed consent; Women of childbearing age must have evidence of negative pregnancy test and be willing to practice birth control after 2 weeks following the cells transfusion. Expected Overall survival ＜ 3 months; The tumor size or quantity is not suitable for interventional treatment or portal vein tumor thrombus; Liver function is Childs Pugh C; Had received TACE therapy previously or in radiotherapy at present,or taking Sola Feeney; Other serious diseases:the heart,lung, kidney, digestive, nervous, mental disorders, immune regulatory diseases, metabolic diseases, infectious diseases, etc; Unable or unwilling to provide informed consent, or fail to comply with the test requirements.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Precision Cells</keyword>
	<keyword>Transcatheter Arterial Chemoembolization</keyword>
	<keyword>Advanced Liver Cancer</keyword>
</DOC>